Rheumatology Research Review, Issue 105

In this issue:

Namilumab in RA
Safety and efficacy of tofacitinib for up to 9.5 years in RA
Withdrawal of infliximab in AS
Early treatment of PsA with TNFi
Stopping TCZ in GCA
Mortality in RA
Conflict of interest and RA trials
Ixekizumab for radiographic axSpA
Pain susceptibility phenotypes and knee OA

Please login below to download this issue (PDF)

Subscribe